| Mrs Kris L Tesio, OD | |
|
7199 Se 29th St, Suite 110-b, Midwest City, OK 73110-6003 | |
| (405) 737-6681 | |
| (405) 737-6681 |
| Full Name | Mrs Kris L Tesio |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 7199 Se 29th St, Midwest City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386721025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1143 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kris L Tesio, OD 7199 Se 29th St, Suite 110-b, Midwest City, OK 73110-6003 Ph: (405) 737-6681 | Mrs Kris L Tesio, OD 7199 Se 29th St, Suite 110-b, Midwest City, OK 73110-6003 Ph: (405) 737-6681 |
News Archive
Cushing disease is a hormone disorder that causes a diverse array of symptoms, including fat accumulation, high blood pressure, osteoporosis, muscle wasting, and ultimately death. It is caused by a tumor in the anterior pituitary gland that results in the secretion of excess amounts of adrenocorticotropic hormone (ACTH). Treatment options are essentially limited to surgical resection. However, tumors commonly recur, meaning that new treatment options are needed.
New York University chemists have employed a computer simulation whose results have enhanced scientific understanding of the DNA transcription process. The study, funded by the National Institutes of Health, appears in the June 7 issue of the Proceedings of the National Academy of Sciences.
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.
› Verified 9 days ago
Dr. Kathleen Yang, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8121 National Ave, Suite 409, Midwest City, OK 73110 Phone: 405-737-8935 Fax: 405-737-8934 | |
Midwest City Eye Care Associates Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 8121 National Ave, Suite 409, Midwest City, OK 73110 Phone: 405-737-8935 Fax: 405-737-8934 | |
Bob Baldwin, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6912 E Reno Ave, Suite 101, Midwest City, OK 73110 Phone: 405-732-2277 Fax: 405-737-4776 | |
Dr. Megan Rae Tucker, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1200 S Air Depot Blvd Ste A, Midwest City, OK 73110 Phone: 405-494-8100 | |
Sawyer Lee, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2008 S Post Rd, Midwest City, OK 73130 Phone: 405-732-2277 Fax: 407-737-4776 | |
Dr. Elizabeth Mccrackin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2008 S Post Rd, Midwest City, OK 73130 Phone: 405-732-2277 Fax: 405-737-4776 | |
Midwest Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 1029 S Post Rd, Midwest City, OK 73130 Phone: 405-737-0713 Fax: 405-732-2225 |